Sleep-disordered breathing, sleepiness, and insulin resistance: Is the latter a consequence, a pathogenetic factor, or both?

Sleep Medicine

Volumn 3, Issue 5, 2002, Pages 389-391

  Vgontzas, Alexandros N ^a   Chrousos, George P ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INTERLEUKIN 6; TESTOSTERONE; TUMOR NECROSIS FACTOR;

ADULT; BODY MASS; BODY WEIGHT; BREATHING DISORDER; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DEVICE; DIABETES MELLITUS; DISEASE ASSOCIATION; EATING HABIT; EDITORIAL; ENVIRONMENTAL FACTOR; EXERCISE; FEMALE; GLUCOSE METABOLISM; HEREDITY; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MEDIATOR; METABOLIC DISORDER; OBESITY; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; POSITIVE END EXPIRATORY PRESSURE; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; SLEEP; SLEEP APNEA SYNDROME; SLEEP DISORDER; SNORING; SOMNOLENCE; SYMPTOMATOLOGY;

EID: 0036749947     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1389-9457(02)00067-9     Document Type: Editorial

References (22)

1. Young T, Palta M, Dempsey J, Skatrud J, et al. The occurrence of sleep disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-1235.
2. Bixler EO, Vgontzas AN, Lin HM, Rein J, et al. Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 2001;163(3 Pt 1):597-598.
3. Vgontzas AN, Bixler EO, Martin LF, Shubert D, et al. Sleep apnea and sleep disruption in obese patients. Arch Intern Med 1994;154:1705-1711.
4. Vgontzas AN, Legro RS, Bixler EO, Grayev A, et al. Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. J Clin Endocrinol Metab 2001;86(2):517-520.
5. Fogel RB, Malhotra A, Pillar G, Pittman SD, et al. Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 2001;86(3):1175-1180.
6. Gopal M, Duntley S, Uhles M, Attarian H. The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome. Sleep Med 2002 in press.
7. Dunaif A. Insulin resistance and the polycystic ovarian syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997;18:774-800.
8. Tolis G, Bringer J, Chrousos GP, editors. Intraovarian regulators and polycystic ovarian syndrome: recent progress on clinical and therapeutic aspects Annals of the New York Academy of Science, vol 687. New York: NY Acad Sci, 1993.
9. Stoohs R, Facchini F, Guilleminault C. Insulin resistance and sleep disordered breathing in healthy humans. Am J Respir Crit Care Med 1996;154:170-174.
10. Davies RJ, Turner R, Crosby J, Stradling JR. Plasma insulin and lipid levels in untreated obstructive sleep apnea and snoring: their comparison with matched controls and response to treatment. J Sleep Res 1994;3:180-185.
11. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
12. Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000;85:1151-1158.
13. Punjabi NM, Sorkin JD, Katzel L, Goldberg A, et al. Sleep-disordered breathing and insulin resistance in middle aged and overweight men. Am J Respir Crit Care Med 2002;165:677-682.
14. Ip SM, Lam B, Ng M, Lam WK, et al. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002;165:670-676.
15. Elmasry A, Janson C, Lindberg E, Gislason T, et al. The role of habitual snoring and obesity in the development of diabetes: a 10-year follow-up study in a male population. J Intern Med 2000;248:13-20.
16. Elmasry A, Lindberg E, Berne C, Janson C, et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001;249:153-161.
17. Vgontzas AN, Papanicolaou DA, Bixler EO, Kales A, et al. Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. J Clin Endocrinol Metab 1997;82:1313-1316.
18. Chrousos GP. The stress response and immune function: clinical implications. The 1999 Novera H. Spector Lecture. Ann N Y Acad Sci 2000;917:38-67.
19. Vgontzas AN, Bixler EO, Tan T-L, Kantner D, et al. Obesity without sleep apnea is associated with daytime sleepiness. Arch Intern Med 1998;158:1333-1337.
20. Bixler EO, Vgontzas AN, Lin H, Leiby B. Excessive daytime sleepiness: association with diabetes. 83rd Endocrine Society Meeting, Denver, CO, 2001. p. 1.
21. Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999;354:1435-1439.
22. Chrousos GP. The role of stress and the hypothalamic-pituitary-adrenal axis in the pathogenesis of the metabolic syndrome: neuro-endocrine and target tissue-related causes (review). Int J Obes 2000;24:S50-S55.